Sandbox Captopril tablet2
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]
For information about , click [[{{{genericName}}}|here]].
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Sandbox Captopril tablet2 is {{{aOrAn}}} {{{drugClass}}} drug that is FDA approved for the treatment of {{{indication}}}. Adverse reactions include {{{adverseReactions}}}.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Condition 1
- Dosing Information
- (Dosage)
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
Condition 1
- Developed by: (Organization)
- Class of Recommendation: (Class) (Link)
- Strength of Evidence: (Category A/B/C) (Link)
- Dosing Information/Recommendation
- (Dosage)
Non–Guideline-Supported Use
Condition 1
- Dosing Information
- There is limited information about Off-Label Non–Guideline-Supported Use of Sandbox Captopril tablet2 in adult patients.==Pediatric Indications and Dosage==
FDA-Labeled Indications and Dosage (Pediatric)
Condition 1
- Dosing Information
- (Dosage)===Off-Label Use and Dosage (Pediatric)===
Guideline-Supported Use
Condition 1
- Developed by: (Organization)
- Class of Recommendation: (Class) (Link)
- Strength of Evidence: (Category A/B/C) (Link)
- Dosing Information/Recommendation
- (Dosage)====Non–Guideline-Supported Use====
Condition 1
- Dosing Information
- There is limited information about Off-Label Non–Guideline-Supported Use of Sandbox Captopril tablet2 in pediatric patients.
Contraindications
- Condition 1
- Condition 2
- Condition 3
- Condition 4
- Condition 5
Warnings
Conidition 1
(Description)
Adverse Reactions
Clinical Trials Experience
Central Nervous System
- (list/description of adverse reactions)
Cardiovascular
- (list/description of adverse reactions)
Respiratory
- (list/description of adverse reactions)
Gastrointestinal
- (list/description of adverse reactions)
Hypersensitive Reactions
- (list/description of adverse reactions)
Miscellaneous
- (list/description of adverse reactions)
Postmarketing Experience
Central Nervous System
- (list/description of adverse reactions)
Cardiovascular
- (list/description of adverse reactions)
Respiratory
- (list/description of adverse reactions)
Gastrointestinal
- (list/description of adverse reactions)
Hypersensitive Reactions
- (list/description of adverse reactions)
Miscellaneous
- (list/description of adverse reactions)
Drug Interactions
- (Drug 1)
- (Description)
- (Drug 2)
- (Description)
- (Drug 3)
- (Description)
Use in Specific Populations
Pregnancy
There is no FDA guidance on usage of Sandbox Captopril tablet2 in women who are pregnant.
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Sandbox Captopril tablet2 in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Sandbox Captopril tablet2 during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Sandbox Captopril tablet2 in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Sandbox Captopril tablet2 in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Sandbox Captopril tablet2 in geriatric settings.
Gender
There is no FDA guidance on the use of Sandbox Captopril tablet2 with respect to specific gender populations.
Race
There is no FDA guidance on the use of Sandbox Captopril tablet2 with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Sandbox Captopril tablet2 in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Sandbox Captopril tablet2 in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Sandbox Captopril tablet2 in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Sandbox Captopril tablet2 in patients who are immunocompromised.